Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Other financing activities (2022 - 2024)

Historic Other financing activities for Phibro Animal Health (PAHC) over the last 3 years, with Q3 2024 value amounting to $10.4 million.

  • Phibro Animal Health's Other financing activities changed N/A to $10.4 million in Q3 2024 from the same period last year, while for Jun 2025 it was $10.4 million, marking a year-over-year change of. This contributed to the annual value of $10.4 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q3 2024, Phibro Animal Health's Other financing activities is $10.4 million.
  • In the past 5 years, Phibro Animal Health's Other financing activities ranged from a high of $10.4 million in Q3 2024 and a low of $71000.0 during Q3 2022
  • Moreover, its 3-year median value for Other financing activities was $701000.0 (2022), whereas its average is $3.0 million.